Home > Journals > International Angiology > Past Issues > International Angiology 2021 April;40(2) > International Angiology 2021 April;40(2):87-96

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

ORIGINAL ARTICLE  CAROTID DISEASE Free accessfree

International Angiology 2021 April;40(2):87-96

DOI: 10.23736/S0392-9590.20.04525-3

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Influence of contralateral carotid artery occlusions on short- and long-term outcomes of carotid artery stenting: a retrospective single-center analysis and review of literature

Renato CASANA 1, 2 , Maurizio DOMANIN 3, 4, Chiara MALLOGGI 2, Valerio S. TOLVA 5, Andrea ODERO Jr 1, Daniele BISSACCO 3, Santi TRIMARCHI 3, 4, Vincenzo SILANI 6, 7, Gianfranco PARATI 8, 9

1 Department of Surgery, IRCCS Istituto Auxologico Italiano, Milan, Italy; 2 Laboratory of Research in Vascular Surgery, IRCCS Istituto Auxologico Italiano, Milan, Italy; 3 Vascular Surgery Unit, IRCCS, Ospedale Maggiore Policlinico, Milan, Italy; 4 Università degli Studi di Milano, Milan, Italy; 5 Department of Vascular and Endovascular Surgery, Policlinico di Monza, Monza, Monza-Brianza, Italy; 6 Department of Neurology-Stroke and Neuroscience, IRCCS Istituto Auxologico Italiano, Ospedale San Luca, Milan, Italy; 7 Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy; 8 Department of Cardiovascular, Neural and Metabolic Sciences, IRCCS Istituto Auxologico Italiano, San Luca Hospital, Milan, Italy; 9 Department of Medicine and Surgery, Università di Milano-Bicocca, Monza, Monza-Brianza, Italy



BACKGROUND: In the current literature, correlations between a contralateral carotid artery occlusion (CCO) with mortality and major adverse cardiac or cerebrovascular events (MACCE) rates after carotid artery stenting (CAS) are often described with controversial conclusions. Moreover, long-term results of mortality, MACCE and restenosis rate are scarcely reported. This study examined the association between a CCO and the short- and long-term outcomes after CAS.
METHODS: One hundred and forty-six patients with CCO and without (No-CCO) who underwent between 2010 and 2017 to a CAS procedure in a single institution were retrospectively evaluated. The primary aim of the study was to evaluate mortality and MACCE rates in the short-term (defined as the occurrence during hospitalization and within 30-day) and after 3-year follow-up. The secondary aim of the study was to examine the restenosis rates in the short- and long-term period.
RESULTS: The overall success of CAS was 99.3% and the 30-day all-cause mortality rate was 0.7% (one death). About MACCE, there were no major strokes in the CCO groups and 1 (1.4%) in the No-CCO group (P=1.00). The rate of 30-day minor strokes was 1.4% (1 patient) in the CCO group and 2.7% (2 patients) in the No-CCO group (P=1.00). In the 3-year follow-up, death occurred in 11 CCO vs. 6 No-CCO patients, respectively (15.1% vs. 8.2%, P=0.30). Regarding MACCE, major stroke occurred in 6 CCO vs. 2 No-CCO patients (8.2% vs. 2.7%, P=0.27), minor stroke in 6 CCO vs. 6 No-CCO (8.2% vs. 8.2%, P=1.0) and myocardial infarction in 6 CCO (8.2%) vs. 3 No-CCO patients (8.2 vs. 4.1%, P=0.49), respectively. Regarding the 30-day restenosis rate, it was observed in one patient (1.4%) in the CCO group while no cases were recorded in the No-CCO group, respectively (P=1.00). In the 3-year follow-up, greater than >50% restenosis was observed in 7 patients (9.6%) in the CCO group and in one patient (1.4%) in the No-CCO group (P=0.06), respectively. Kaplan-Meier survival analysis revealed that CCO patients had a lower 3-year freedom from restenosis rate with respect to the No-CCO group (87.6% vs. 98.6%, P=0.024). A Cox regression model on 3-year restenosis highlighted female gender and hypertension to be statistically significant predictors of restenosis.
CONCLUSIONS: Patients with a preexisting CCO did not show a significative increased risk of procedural adverse events after CAS both in the immediate and long-term follow-up, but on the long term they are more likely to experience restenosis. CCO condition should be considered always as a clinical manifestation of a more aggressive carotid atherosclerosis.


KEY WORDS: Carotid arteries; Carotid artery diseases; Stents

top of page